Janus Henderson Group PLC Vir Biotechnology, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 37,057 shares of VIR stock, worth $274,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,057

Previous 37,057 -0.0%

Holding current value

$274,221

Previous $329,000 15.81%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.63 - $12.66 $3,479 - $5,772	-456 Reduced 1.22%	37,057 $329,000
Q1 2024 May 15, 2024	BUY	$8.6 - $11.9 $43 - $59	5 Added 0.01%	37,513 $380,000
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $442 - $586	-57 Reduced 0.15%	37,508 $377,000
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $127 - $344	14 Added 0.04%	37,565 $351,000
Q2 2023 Aug 14, 2023	SELL	$23.2 - $27.29 $3,828 - $4,502	-165 Reduced 0.44%	37,551 $921,000
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $545,859 - $756,503	24,522 Added 185.86%	37,716 $877,000
Q4 2022 Feb 14, 2023	SELL	$19.96 - $28.22 $19 - $28	-1 Reduced 0.01%	13,194 $333,000
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $3,067 - $5,224	-168 Reduced 1.26%	13,195 $255,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $5,361 - $7,502	281 Added 2.15%	13,363 $340,000
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $466 - $880	22 Added 0.17%	13,082 $336,000
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $898,222 - $1.57 Million	-29,003 Reduced 68.95%	13,060 $547,000
Q3 2021 Nov 16, 2021	BUY	$34.9 - $54.54 $1.47 Million - $2.29 Million	42,063 New	42,063 $1.83 Million
Q3 2020 Nov 16, 2020	SELL	$28.28 - $53.6 $26.9 Million - $50.9 Million	-950,310 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $26.5 Million - $45.5 Million	950,310 New	950,310 $38.9 Million

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Vir Biotechnology, Inc. Transaction History